Categories

10000 to 4crs in 18 months 1000rs to 50crs 300% returns 75% promoter holdings A 50 bagger A sureshot 5 bagger Analysis Another fraud? Auto ancillaries Bank sector Blind sell Brand plays Broking Bse Nse Buy calls cements Ceramics/tiles Counters I don't like Debt free businesses Delisting candidates demerger bets Disclosure- I own them Domestic consumption plays E-Commerce pick Education Exit at rallies Famous analysts Famous stocks FMCG Footwear future multibaggers Gems andJewellery Hidden gems High conviction ideas High dividend plays High potential small caps High ROE stocks Holding companies Hotel sector How they looted you.. Indian stock market Infrastructure sector Interesting Microcaps IT KPO Landbank plays largecap ideas Less than 5 PE stocks Liquor Logistics Market lessons Market outlook for 2013 and 2014 Market underperformers Meeting with the CEO Metals Monopoly businesses My 5 baggers My Favourite counters My paid stock recommendations My stock picking techniques nse bse tips Oil exploration Operator calls Paints Penny stock outlook penny stock updates Pharma sector Poultry stocks PSU Publicity freaks Real estate Renewable energy plays Safe bets Sell recommendations Share market Live shipping stocks short term call SOTP plays stock tips stock under 10rs Stocks to watch out for Strong bonus candidates Takeover candidates TATA product tea Textiles The 13 bagger The 45 bagger Trading companies Transformers Turnaround bets Tyres Uncertain/Risky business models Unique businesses

Search This Blog(Over 800 companies covered in the blog).

Please note

Note: The artciles are not research reports but assimilation of information available on public domain and it should not be treated as a research report.

Registration status with SEBI: I am not registered with SEBI under the (Research Analyst) regulations 2014 and as per clarifications provided by SEBI: “Any person who makes recommendation or offers an opinion concerning securities or public offers only through public media is not required to obtain registration as research analyst under RA Regulations”

Disclosure: It is safe to assume that I might have the dkiscussed companies in my portfolio and hence my point of view can be biased.Readers should consult registered consultants before making any investments
.

Archives : Old artciles

Friday, December 18, 2009

Ajanta Pharma Ltd:Buy/sell/hold,growth prospects and recomendation,news and results,target price and analysis

Scripscan:Ajanta Pharma Ltd
Code:532331
cmp:100

Story:Ajanta Pharma Limited engages in the research, manufacture, and marketing of various pharmaceutical products principally in India.The company provides a range of therapeutic products covering segments, such as cardiology, dermatology, and ophthalmology, as well as anti retrovirals and anti malarials; and markets over-the-counter drugs. It offers pharmaceutical products in allopathic and herbal forms. The company’s allopathic products include anthelmintics, antibiotics, anti diarrhoeal, NSAIDs, analgesics, antyretics, anti histaminics, anti malarials, anti retrovirals, anti tussives/bronchodilator, anti tuberculosis, cardiovasculars, gastrointestinal, gynaecology and hormone, male erectile dysfunction, and nutraceutical/multivitamin products. Ajanta Pharma’s herbal products comprise aphrodisiac/energizers, digestive aids, metabolic correctives, and respiratory related products. The company offers its products in various forms, such as tablets, capsules, injections, ointments, and powders. It exports its products to 50 countries in Asia, Africa, Latin America, Europe, and the Commonwealth of Independent States.Its strong team of 2000 people comprises of a dedicated team of over 100 research scientists. The manufacturing plants comply with the highest regulatory guidelines.The company has been doing quite decent on the operatiional front.It enjoys a bood brand image,a regular dividend payer with management being neat and commited towards increasing the shareholder"s heaath.The same can be stem from the fact that it announced a buyback which gives tremendous confidence and conviction upon the outlook and future prospect of the company.At rs 100 its quoting a low single digit valuations its 1 year forward earnings.Looks worthbuying at present levels.

Important Disclaimer&Privacy policy

This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
 
x

Subscription to Arunthestocksguru

Enter your email address:

Delivered by FeedBurner